Class information for:
Level 1: CELLULAR ONCOL//HPV 16//HUMAN PAPILLOMAVIRUS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
2543 2212 43.9 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
112 3       CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY 70812
32 2             HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER 32910
2543 1                   CELLULAR ONCOL//HPV 16//HUMAN PAPILLOMAVIRUS 2212

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CELLULAR ONCOL address 266754 5% 19% 102
2 HPV 16 authKW 242785 4% 20% 88
3 HUMAN PAPILLOMAVIRUS authKW 230944 15% 5% 338
4 PAPILLOMAVIRUS authKW 199880 5% 13% 111
5 VIRUS LIKE PARTICLES authKW 151777 5% 10% 111
6 E7 authKW 121300 2% 18% 48
7 EMMY NOETHER GRP VIRUS ENDOCYTOSIS address 110421 0% 100% 8
8 THERAPEUTIC VACCINE authKW 108456 2% 16% 48
9 L2 authKW 104234 2% 22% 34
10 HPV authKW 100836 8% 4% 169

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Virology 37164 31% 0% 691
2 Immunology 5476 25% 0% 550
3 Medicine, Research & Experimental 2999 15% 0% 323
4 Oncology 2956 20% 0% 451
5 Biotechnology & Applied Microbiology 1510 12% 0% 272
6 Infectious Diseases 1063 7% 0% 160
7 Microbiology 488 8% 0% 168
8 Obstetrics & Gynecology 258 4% 0% 90
9 Dermatology 71 2% 0% 42
10 Genetics & Heredity 40 3% 0% 73

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CELLULAR ONCOL 266754 5% 19% 102
2 EMMY NOETHER GRP VIRUS ENDOCYTOSIS 110421 0% 100% 8
3 HM BLIGH CANC 96618 0% 100% 7
4 JAKE GITTLEN CANC 94210 1% 26% 26
5 JAKE GITTLEN CANC FDN 79065 1% 30% 19
6 YALE SKIN DIS 62109 0% 75% 6
7 MOL VIROL MED BIOCHEM 57509 0% 83% 5
8 IMMUNOL CANC 51875 2% 8% 50
9 IMUL 44167 0% 80% 4
10 LIONS HUMAN IMMUNOL S 41408 0% 100% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 VACCINE 16825 7% 1% 149
2 VIROLOGY 15703 7% 1% 146
3 JOURNAL OF VIROLOGY 11992 8% 0% 187
4 JOURNAL OF GENERAL VIROLOGY 8821 4% 1% 93
5 VIRAL IMMUNOLOGY 6354 1% 2% 23
6 INTERNATIONAL JOURNAL OF CANCER 5186 4% 0% 88
7 CLINICAL AND VACCINE IMMUNOLOGY 3780 1% 1% 27
8 CANCER IMMUNOLOGY IMMUNOTHERAPY 2444 1% 1% 28
9 JOURNAL OF MEDICAL VIROLOGY 2423 2% 0% 37
10 HUMAN VACCINES & IMMUNOTHERAPEUTICS 2334 1% 1% 17

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 HPV 16 242785 4% 20% 88 Search HPV+16 Search HPV+16
2 HUMAN PAPILLOMAVIRUS 230944 15% 5% 338 Search HUMAN+PAPILLOMAVIRUS Search HUMAN+PAPILLOMAVIRUS
3 PAPILLOMAVIRUS 199880 5% 13% 111 Search PAPILLOMAVIRUS Search PAPILLOMAVIRUS
4 VIRUS LIKE PARTICLES 151777 5% 10% 111 Search VIRUS+LIKE+PARTICLES Search VIRUS+LIKE+PARTICLES
5 E7 121300 2% 18% 48 Search E7 Search E7
6 THERAPEUTIC VACCINE 108456 2% 16% 48 Search THERAPEUTIC+VACCINE Search THERAPEUTIC+VACCINE
7 L2 104234 2% 22% 34 Search L2 Search L2
8 HPV 100836 8% 4% 169 Search HPV Search HPV
9 PROPHYLACTIC VACCINE 99990 1% 32% 23 Search PROPHYLACTIC+VACCINE Search PROPHYLACTIC+VACCINE
10 PSEUDOVIRION 90637 1% 39% 17 Search PSEUDOVIRION Search PSEUDOVIRION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WANG, JW , RODEN, RBS , (2013) L2, THE MINOR CAPSID PROTEIN OF PAPILLOMAVIRUS.VIROLOGY. VOL. 445. ISSUE 1-2. P. 175-186 97 85% 33
2 SU, JH , WU, AJ , SCOTNEY, E , MA, B , MONIE, A , HUNG, CF , WU, TC , (2010) IMMUNOTHERAPY FOR CERVICAL CANCER RESEARCH STATUS AND CLINICAL POTENTIAL.BIODRUGS. VOL. 24. ISSUE 2. P. 109 -129 122 72% 42
3 RODEN, RBS , LING, M , WU, TC , (2004) VACCINATION TO PREVENT AND TREAT CERVICAL CANCER.HUMAN PATHOLOGY. VOL. 35. ISSUE 8. P. 971-982 126 78% 56
4 LIN, YY , ALPHS, H , HUNG, CF , RODEN, RBS , WU, TC , (2007) VACCINES AGAINST HUMAN PAPILLOMAVIRUS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 12. ISSUE . P. 246 -264 116 78% 8
5 FLORIN, L , SAPP, M , SPODEN, GA , (2012) HOST-CELL FACTORS INVOLVED IN PAPILLOMAVIRUS ENTRY.MEDICAL MICROBIOLOGY AND IMMUNOLOGY. VOL. 201. ISSUE 4. P. 437 -448 94 82% 9
6 BIRYUKOV, J , MEYERS, C , (2015) PAPILLOMAVIRUS INFECTIOUS PATHWAYS: A COMPARISON OF SYSTEMS.VIRUSES-BASEL. VOL. 7. ISSUE 8. P. 4303 -4325 90 80% 1
7 HUNG, CF , MA, B , MONIE, A , TSEN, SW , WU, TC , (2008) THERAPEUTIC HUMAN PAPILLOMAVIRUS VACCINES: CURRENT CLINICAL TRIALS AND FUTURE DIRECTIONS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 8. ISSUE 4. P. 421-439 99 74% 65
8 PANATTO, D , AMICIZIA, D , BRAGAZZI, NL , RIZZITELLI, E , TRAMALLONI, D , VALLE, I , GASPARINI, R , (2015) HUMAN PAPILLOMAVIRUS VACCINE: STATE OF THE ART AND FUTURE PERSPECTIVES.ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101. VOL. 101. ISSUE . P. 231 -322 163 39% 1
9 MONIE, A , HUNG, CF , WU, TC , (2007) PREVENTIVE AND THERAPEUTIC HPV VACCINES.CURRENT OPINION IN INVESTIGATIONAL DRUGS. VOL. 8. ISSUE 12. P. 1038 -1050 95 79% 10
10 DAY, PM , SCHELHAAS, M , (2014) CONCEPTS OF PAPILLOMAVIRUS ENTRY INTO HOST CELLS.CURRENT OPINION IN VIROLOGY. VOL. 4. ISSUE . P. 24-31 68 82% 13

Classes with closest relation at Level 1


Rank Class id link
1 456 E6//PAPILLOMAVIRUS//E7
2 18512 POLYOMAVIRUS VP1//PROT EXP S IL//SECT VIROL ONCOL
3 759 HPV VACCINE//HPV VACCINATION//HUMAN PAPILLOMAVIRUS VACCINE
4 8402 EPIDERMODYSPLASIA VERRUCIFORMIS//BETAPAPILLOMAVIRUS//PAPILLOMAVIRUS
5 117 HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER
6 17481 SECT MICROBIOL MED BIOTECHNOL//HUMAN PAPILLOMAVIRUS//SPERM INFECTION
7 34386 MOL BIOL VIRAL ONCOGENESIS//HYPERVARIABLE EPITOPE CONSTRUCTS//LENTIVIRAL VLP
8 15454 CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA
9 6009 HUMAN PAPILLOMAVIRUS//BOWENOID PAPULOSIS//PEOSCOPY
10 21444 INTERDISCIPLINARY STUDIES SECT//HLA DQB1//6Q 15

Go to start page